Clinical Trial

From PSA to Stockholm3: Study Part 1

Study acronym: PSA2STHLM3/1
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This part of the project aims to analyze the effectiveness of the Stockholm3 test in regular clinical practice, both in general practice and in the specialist health care, as a tool for detecting patients who need further diagnostics for prostate cancer.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2017-12-20; most recent amendment 2023-04-21.
Status change: Recruiting → Active, Not Recruiting 2023-01-30
Status change: Active, Not Recruiting → Recruiting 2020-10-27
Status change: Recruiting → Active, Not Recruiting 2019-07-23
Trial Details
NCT Number NCT03381105
Lead Sponsor Helse Stavanger HF
Collaborators: Karolinska Institutet
Conditions Prostate Cancer
Enrollment 13,431 participants
Start Date 2017-09-01
Primary Completion 2021-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-04-24